Articles related to DEPRESSION

Gain insights into the challenges and nuances of diagnosing and treating Depressive Mixed States, a newly classified condition that requires a specialized approach for effective management.

Explore the paradigm shift in depression treatment from chemical imbalances to neuroplasticity, and discover how this emerging concept could revolutionize therapeutic approaches.

Explore how a paradigm shift from monoamine to GABAergic systems could offer new, more effective treatments for major depressive disorder; the latest review discusses the unmet needs and the promising potential of NAS GABAA receptor PAMs.

Discover the implications of a newly identified depression subtype, “cognitive biotype,” which not only presents with significant cognitive impairments but also shows resistance to standard antidepressant treatments.

Discover the advancements in MDD pharmacotherapy that promise to expand treatment options and address unmet needs.

With a focus on evidence-based best practices, this activity will equip you with the tools to translate screening scores, confidently switch between therapies, and differentiate between alternative treatment options.